The Journal of Organic Chemistry
Article
(99.5:0.5 to 95:5 dichloromethane/EtOAc) to afford product 11a as a
tan oil (0.0441 g, 0.169 mmol, 48%). H NMR (500 MHz, CDCl3) δ
(s), 1308 (s) cm−1. HRMS (ESI): m/z calcd for C18H23N2 [M + H]+
267.1861, found 267.1860.
1
2-((Dimethylamino)methyl)-N-(4-methoxyphenyl)aniline (16a).
Following representative procedure A using substrate 1 (0.0996 g,
0.381 mmol) and p-anisidine (0.0943 g, 0.766 mmol), the crude
mixture (ratio45 16a/2b 94:6) was purified by silica gel column
chromatography (98:2 dichloromethane/EtOAc then switching to
89:10:1 dichloromethane/EtOAc/triethylamine) to afford product 16a
8.50 (br s, 1H), 7.28−7.24 (m, 3H), 7.11 (dd, J = 8.7, 2.5 Hz, 1H),
7.06−7.05 (m, 3H), 6.91 (t, J = 7.4 Hz, 1H), 3.41 (s, 2H), 2.24 (s,
6H); 13C{1H} NMR (125 MHz, CDCl3) δ 142.8, 142.5, 130.1, 129.3,
127.8, 127.2, 123.5, 120.7, 118.1, 115.9, 63.1, 44.8; IR (thin film,
CDCl3) 3244 (br), 3029 (m), 2978 (m), 2947 (m), 2855 (m), 2822
(m), 2775 (m), 1592 (s), 1514 (s), 1474 (s), 1408 (s), 1321 (s) cm−1.
HRMS (CI): m/z calcd for C15H18ClN2 [M + H]+ 261.1158, found
261.1149.
Ethyl 4-((dimethylamino)methyl)-3-(phenylamino)benzoate
(12a). Following representative procedure A, without base, using
substrate 3169 (0.100 g, 0.300 mmol), the crude mixture (ratio45 12a/
12b 100:0) was purified by silica gel column chromatography (99:1 to
90:10 dichloromethane/EtOAc) to afford product 12a as a yellow oil
(0.0675 g, 0.226 mmol, 75%). 1H NMR (500 MHz, CDCl3) δ 8.67 (br
s, 1H), 8.01 (d, J = 1.6 Hz, 1H), 7.46 (dd, J = 7.8, 1.6 Hz, 1H), 7.29 (t,
J = 8.4 Hz, 2H), 7.14−7.10 (m, 3H), 6.93 (t, J = 7.4 Hz, 1H), 4.33 (q,
J = 7.2 Hz, 2H), 3.49 (s, 2H), 2.24 (s, 6H), 1.35 (t, J = 7.2 Hz, 3H);
13C{1H} NMR (125 MHz, CDCl3) δ 166.8, 143.9, 142.6, 130.4, 130.3,
1
as a tan solid (0.0496 g, 0.193 mmol, 51%): mp 65.5−67.7 °C; H
NMR (400 MHz, CDCl3) δ 8.31 (br s, 1H), 7.17−7.07 (m, 5H), 6.88
(d, J = 8.8 Hz, 2H), 6.74 (ddd, J = 7.0, 7.0, 2.0 Hz, 1H), 3.82 (s, 3H),
3.49 (s, 2H), 2.26 (s, 6H); 13C{1H} NMR (125 MHz, CDCl3) δ 154.5,
145.5, 136.3, 130.4, 128.1, 124.3, 121.6, 118.1, 114.5, 113.2, 63.6, 55.5,
44.7; IR (thin film, CDCl3) 3249 (br), 3105 (m), 3040 (m), 2976 (m),
2946 (s), 2904 (m), 2855 (m), 2820 (s), 2773 (s), 1601 (s), 1510 (s),
1458 (s), 1405 (m), 1362 (m), 1328 (s) cm−1. HRMS (ESI): m/z
calcd for C16H21N2O [M + H]+ 257.1654, found 257.1647.
N-(4-Chlorophenyl)-2-((dimethylamino)methyl)aniline (17a).
Following representative procedure A using substrate 1 (0.075 g,
0.287 mmol) and 4-chloroaniline (0.0732 g, 0.574 mmol), the crude
mixture (ratio45 17a/2b 97:3) was purified by silica gel column
chromatography (9:1 dichloromethane/EtOAc) to afford product 17a
130.2, 129.3, 120.8, 120.2, 118.1, 115.3, 63.3, 60.8, 44.8, 14.3; IR (thin
film, CDCl3) 3238 (br), 3109 (m), 3020 (m), 2979 (m), 2947 (m),
2904 (m), 2856 (m), 2822 (m), 2777 (m), 1715 (s), 1595 (s), 1577
(s), 1530 (s), 1497 (s), 1445 (s), 1423 (s) cm−1. HRMS (CI): m/z
calcd for C18H23N2O2 [M + H]+ 299.1760, found 299.1753.
1
as a brown oil (0.0467 g, 0.179 mmol, 62%). H NMR (500 MHz,
CDCl3) δ 8.28 (br s, 1H), 7.28 (d, J = 7.6 Hz, 1H), 7.20−7.16 (m,
3H), 7.08 (dd, J = 7.4, 1.3 Hz, 1H), 7.00 (d, J = 8.7 Hz, 2H), 6.81
(ddd, J = 7.4, 7.4, 0.8 Hz, 1H), 3.44 (s, 2H), 2.23 (s, 6H); 13C{1H}
NMR (125 MHz, CDCl3) δ 143.3, 141.9, 130.6, 129.1, 128.1, 125.9,
124.5, 119.7, 118.8, 115.1, 63.5, 44.8; IR (thin film, CDCl3) 3238 (br),
3178 (m), 3097 (m), 3025 (m), 2978 (m), 2946 (m), 2856 (m), 2821
(m), 2775 (m), 1591 (s), 1520 (s), 1492 (s), 1327 (s), 1310 (s) cm−1.
HRMS (CI): m/z calcd for C15H18ClN2 [M + H]+ 261.1158, found
261.1166.
5-Bromo-2-((dimethylamino)methyl)-N-phenylaniline (13a). Fol-
lowing representative procedure A, without base, using substrate 3269
(0.100 g, 0.294 mmol), the crude mixture (ratio45 13a/13b 64:36) was
purified by silica gel column chromatography (99:1 to 95:5
dichloromethane/EtOAc) to afford product 13a as a yellow oil
(0.0405 g, 0.133 mmol, 45%). 1H NMR (500 MHz, CDCl3) δ 8.69 (br
s, 1H), 7.42 (d, J = 1.7 Hz, 1H), 7.29 (t, J = 8.2 Hz, 2H), 7.09 (d, J =
7.7 Hz, 2H), 6.95 (t, J = 7.4 Hz, 1H), 6.91 (d, J = 8.0 Hz, 1H), 6.87
(dd, J = 7.9, 1.8 Hz, 1H), 3.40 (s, 2H), 2.22 (s, 6H); 13C{1H} NMR
(100 MHz, CDCl3) δ 145.5, 142.2, 131.6, 129.4, 123.9, 122.1, 121.5,
121.4, 119.0, 116.7, 63.1, 44.7; IR (thin film, CDCl3) 3233 (br), 3092
(m), 3030 (m), 2977 (s), 2945 (s), 2857 (m), 2821 (s), 2774 (s),
1591 (s), 1576 (s), 1516 (s), 1497 (s), 1470 (s), 1411 (s), 1361 (m),
1324 (m) cm−1. HRMS (CI): m/z calcd for C15H18BrN2 [M + H]+
305.0653, found 305.0640.
N-(3-Chlorophenyl)-2-((dimethylamino)methyl)aniline (18a).
Following representative procedure A using substrate 1 (0.100 g,
0.383 mmol) and 3-chloroaniline (0.081 mL, 0.766 mmol), the crude
mixture (ratio45 18a/2b 89:11) was purified by silica gel column
chromatography (95:5 dichloromethane/EtOAc) to afford product
1
18a as a tan oil (0.0486 g, 0.186 mmol, 49%). H NMR (500 MHz,
CDCl3) δ 8.68 (br s, 1H), 7.35 (dd, J = 8.1, 0.6 Hz, 1H), 7.20 (td, J =
7.7, 1.6 Hz, 1H), 7.13 (t, J = 8.1 Hz, 1H), 7.09 (dd, J = 7.4, 1.3 Hz,
1H), 7.06 (t, J = 2.1 Hz, 1H), 6.95−6.93 (m, 1H), 6.85−6.80 (m, 2H),
3.43 (s, 2H), 2.22 (s, 6H); 13C{1H} NMR (125 MHz, CDCl3) δ 144.7,
142.7, 134.8, 130.5, 130.2, 128.1, 126.4, 120.2, 119.7, 116.8, 115.9,
115.2, 63.5, 44.8; IR (thin film, CDCl3) 3237 (br), 3178 (m), 3099
(m), 3057 (m), 3025 (m), 2946 (m), 2858 (m), 2822 (m), 2776 (m),
1589 (s), 1523 (s), 1480 (s), 1329 (s), 1309 (s) cm−1. HRMS (CI):
m/z calcd for C15H18ClN2 [M + H]+ 261.1158, found 261.1151.
2-Chloro-N-(2-((dimethylamino)methyl)phenyl)aniline (19a).
Following representative procedure A, without base, using substrate
1 (0.100 g, 0.383 mmol) and 2-chloroaniline (0.081 mL, 0.766 mmol),
the crude mixture (ratio45 19a/2b 66:33) was purified by silica gel
column chromatography (99:1 to 98:2 dichloromethane/EtOAc) to
afford product 19a as a tan oil (0.0355 g, 0.136 mmol, 36%). 1H NMR
(400 MHz, CDCl3) δ 9.18 (br s, 1H), 7.39 (d, J = 8.2 Hz, 2H), 7.35
(d, J = 7.9 Hz, 1H), 7.20 (t, J = 8.2 Hz, 1H), 7.13−7.09 (m, 2H), 6.86
(t, J = 7.4 Hz, 1H), 6.76 (t, J = 7.8 Hz, 1H), 3.44 (s, 2H), 2.25 (s, 6H);
13C{1H} NMR (125 MHz, CDCl3) δ 142.3, 140.3, 130.5, 129.9, 127.9,
127.4, 127.1, 122.1, 120.3, 119.7, 116.4, 115.7, 63.1, 44.5; IR (thin film,
CDCl3) 3218 (br), 3038 (m), 2976 (m), 2945 (m), 2857 (m), 2820
(m), 2774 (m), 1590 (s), 1525 (s), 1482 (m), 1466 (s), 1361 (m),
1329 (m), 1309 (m) cm−1. HRMS (ESI): m/z calcd for C15H18ClN2
[M + H]+ 261.1158, found 261.1166.
2-((Dimethylamino)methyl)-5-methyl-N-phenylaniline (14a). Fol-
lowing representative procedure A, without base, using substrate 3369
(0.100 g, 0.343 mmol), the crude mixture (ratio45 14a/14b 100:0) was
treated with trimethylethylenediamine (0.15 mL), then purified by
column chromatography (99:1 to 90:10 dichloromethane/EtOAc) to
1
afford product 14a as an orange oil (0.0517 g, 0.215 mmol, 59%). H
NMR (400 MHz, CDCl3) δ 8.46 (br s, 1H), 7.25 (t, J = 7.5 Hz, 2H),
7.18 (s, 1H), 7.09 (d, J = 7.6 Hz, 2H), 6.96 (d, J = 7.5 Hz, 1H), 6.87 (t,
J = 7.3 Hz, 1H), 6.60 (d, J = 7.5 Hz, 1H), 3.40 (s, 2H), 2.27 (s, 3H),
2.21 (s, 6H); 13C{1H} NMR (100 MHz, CDCl3) δ 143.5, 143.3, 137.8,
130.4, 129.2, 122.9, 120.1, 120.0, 117.9, 115.6, 63.2, 44.7, 21.4; IR
(thin film, CDCl3) 3250 (br), 3044 (m), 2976 (m), 2945 (m), 2855
(m), 2819 (m), 2773 (m), 1616 (m), 1593 (s), 1529 (s), 1497 (s),
1454 (s), 1417 (s), 1360 (m), 1325 (m), 1307 (m) cm−1. HRMS
(ESI): m/z calcd for C16H21N2 [M + H]+ 241.1705, found 241.1708.
N-Phenyl-2-(piperidin-1-ylmethyl)aniline (15a). Following repre-
sentative procedure A, without base, using substrate 2669 (0.104 g,
0.345 mmol), the crude mixture (ratio45 15a/15b 100:0) was purified
by silica gel column chromatography (99:1 to 90:10 dichloromethane/
EtOAc) to afford product 15a as a tan oil (0.0537 g, 0.202 mmol,
58%). 1H NMR (500 MHz, CDCl3) δ 9.02 (br s, 1H), 7.35 (d, J = 8.1
Hz, 1H), 7.28−7.24 (m, 2H), 7.16 (t, J = 7.6 Hz, 1H), 7.09 (d, J = 8.3
Hz, 2H), 7.07 (d, J = 7.4 Hz, 1H), 6.89 (t, J = 7.4 Hz, 1H), 6.77 (t, J =
7.4 Hz, 1H), 3.51 (s, 2H), 2.51−2.27 (m, 4H), 1.61 (qn, J = 5.6 Hz,
4H), 1.57−1.44 (m, 2H); 13C{1H} NMR (125 MHz, CDCl3) δ 143.8,
143.2, 130.5, 129.2, 127.9, 124.9, 120.2, 117.9, 114.1, 62.9, 53.8, 26.3,
24.4; IR (thin film, CDCl3) 3236 (br), 3106 (m), 3045 (m), 2934 (s),
2851 (m), 2802 (m), 2758 (m), 1727 (m), 1593 (s), 1523 (s), 1497
(s), 1476 (s), 1462 (s), 1442 (s), 1390 (s), 1367 (s), 1342 (s), 1325
N-(4-Bromophenyl)-2-((dimethylamino)methyl)aniline (20a).
Following representative procedure A using substrate 1 (0.075 g,
0.287 mmol) and 4-bromoaniline (0.0987 mg, 0.574 mmol), the crude
mixture (ratio45 20a/2b 96:4) was purified by silica gel column
chromatography (9:1 dichloromethane/EtOAc then 99:1 EtOAc/
triethylamine) to afford product 20a as a brown solid (0.0510 g, 0.167
mmol, 58%): mp 95.4−96.8 °C; 1H NMR (500 MHz, CDCl3) δ 8.59
(br s, 1H), 7.34−7.28 (m, 3H), 7.18 (app t, J = 8.3 Hz, 1H), 7.09 (d, J
H
J. Org. Chem. XXXX, XXX, XXX−XXX